AT&T Other Income (Expense) decreased by 127.8% to -$1.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 631.6%, from $237.00M to -$1.26B. Over 2 years (FY 2021 to FY 2024), Other Income (Expense) shows a downward trend with a -15.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$452.00M | $78.00M | $1.25B | $1.05B | $1.30B | $1.24B | -$235.00M | -$241.00M | -$802.00M | -$2.34B | -$978.00M | -$669.00M | -$686.00M | -$18.00M | $237.00M | -$403.00M | $4.53B | -$1.26B |
| QoQ Change | — | +117.3% | >999% | -15.6% | +24.0% | -4.8% | -118.9% | -2.6% | -232.8% | -191.1% | +58.1% | +31.6% | -2.5% | +97.4% | >999% | -270.0% | >999% | -127.8% |
| YoY Change | — | — | — | — | +388.5% | >999% | -122.3% | -118.5% | -164.6% | — | -316.2% | -177.6% | +14.5% | +99.2% | +124.2% | +39.8% | +760.9% | -631.6% |